Carina Perrotta, RPAC

Carina Perrotta practices at Dr Donna a Serure, Dermatology & Cosmetic Laser Surgery in Smithtown, New York.

Carina Perrotta's NPI, 1699071159, was assigned on February 1, 2011. Carina Perrotta holds New York license 009388.

Carina Perrotta's primary practice is Dr Donna a Serure, Dermatology & Cosmetic Laser Surgery, at 327 E Main St, Smithtown, NY 11787 in Suffolk County. The practice phone is (631) 979-0909.

Carina Perrotta's primary practice is Dr Donna a Serure, Dermatology & Cosmetic Laser Surgery in Smithtown, New York. The medical group on file is Rockville Dermatology. Dmand AI also links Carina Perrotta to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Carina Perrotta practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Carina Perrotta's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Carina Perrotta is licensed in New York.

CMS data shows 3,329 Medicare services from Carina Perrotta across 12 procedure codes in 2024, for 824 Medicare patients. Medicare paid $135,303 for them. Every service was in an office.

CMS counts 824 Medicare patients who saw Carina Perrotta in 2024. The largest group is 65 to 74, with 369 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Carina Perrotta's median patient age at 59, with 64% women.

In 2024, Carina Perrotta wrote 694 Medicare Part D claims for 351 patients. 86% of them were for generic drugs. CMS names the drug for 549 of them, across 17 drugs with 11 or more claims each, at $85,570 in total drug cost. In 2023, CMS named 398 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 62 out of 100 for Carina Perrotta for performance year 2024, reported individually. Carina Perrotta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 133 general payments to Carina Perrotta from 22 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $734.